Literature DB >> 22561551

Neuroimaging as a tool to investigate how cognitive factors influence analgesic drug outcomes.

Ulrike Bingel1, Irene Tracey, Katja Wiech.   

Abstract

The observation that cognitive factors such as beliefs and expectations not only modulate the perception of pain, but also the therapeutic benefit and adverse effects of any pharmacological treatment is not new. However, the contribution of cognitive factors to pharmacotherapy is still poorly understood and far from being systematically exploited to maximize treatment outcome. Recent insights into placebo and nocebo phenomena and their underlying neurobiological mechanisms have, however, rekindled the interest in interactions between pharmacological effects and cognitive factors. In this review, we argue that modern non-invasive neuroimaging techniques exploring structure and function of the brain as well as neurochemical processes can aid in understanding these potential interactions at a more fundamental level. Taking pain as an example, we portrait recent advances in this field and discuss basic science and clinical implications.
Copyright © 2012. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22561551     DOI: 10.1016/j.neulet.2012.04.043

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

Review 1.  The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations.

Authors:  Shannon M Smith; Robert H Dworkin; Dennis C Turk; Ralf Baron; Michael Polydefkis; Irene Tracey; David Borsook; Robert R Edwards; Richard E Harris; Tor D Wager; Lars Arendt-Nielsen; Laurie B Burke; Daniel B Carr; Amy Chappell; John T Farrar; Roy Freeman; Ian Gilron; Veeraindar Goli; Juergen Haeussler; Troels Jensen; Nathaniel P Katz; Jeffrey Kent; Ernest A Kopecky; David A Lee; William Maixner; John D Markman; Justin C McArthur; Michael P McDermott; Lav Parvathenani; Srinivasa N Raja; Bob A Rappaport; Andrew S C Rice; Michael C Rowbotham; Jeffrey K Tobias; Ajay D Wasan; James Witter
Journal:  J Pain       Date:  2017-02-27       Impact factor: 5.820

2.  Deactivation of excitatory neurons in the prelimbic cortex via Cdk5 promotes pain sensation and anxiety.

Authors:  Guo-Qiang Wang; Cheng Cen; Chong Li; Shuai Cao; Ning Wang; Zheng Zhou; Xue-Mei Liu; Yu Xu; Na-Xi Tian; Ying Zhang; Jun Wang; Li-Ping Wang; Yun Wang
Journal:  Nat Commun       Date:  2015-07-16       Impact factor: 14.919

3.  A virtual experimenter to increase standardization for the investigation of placebo effects.

Authors:  Bjoern Horing; Nathan D Newsome; Paul Enck; Sabarish V Babu; Eric R Muth
Journal:  BMC Med Res Methodol       Date:  2016-07-18       Impact factor: 4.615

4.  dmPFC-vlPAG projection neurons contribute to pain threshold maintenance and antianxiety behaviors.

Authors:  Jun-Bin Yin; Shao-Hua Liang; Fei Li; Wen-Jun Zhao; Yang Bai; Yi Sun; Zhen-Yu Wu; Tan Ding; Yan Sun; Hai-Xia Liu; Ya-Cheng Lu; Ting Zhang; Jing Huang; Tao Chen; Hui Li; Zhou-Feng Chen; Jing Cao; Rui Ren; Ya-Nan Peng; Juan Yang; Wei-Dong Zang; Xiang Li; Yu-Lin Dong; Yun-Qing Li
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 19.456

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.